12 Health Care Stocks Moving In Monday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's pre-market session, several healthcare stocks experienced significant movements. EyePoint Pharmaceuticals (EYPT) saw a dramatic increase of 378.8%, while Alterity Therapeutics (ATHE) and Lucy Scientific Discovery (LSDI) also posted substantial gains. On the downside, NexImmune (NEXI) and Panbela Therapeutics (PBLA) experienced notable declines, along with other companies such as Sana Biotechnology (SANA) and Vivos Therapeutics (VVOS).
December 04, 2023 | 1:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
NexImmune stock fell by 36.7% to $3.83, with a market cap of $4.0 million.
The significant pre-market decline for NexImmune suggests negative investor sentiment that could lead to further short-term price decreases once the market opens.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
Panbela Therapeutics shares declined by 14.32% to $0.51, with a market cap of $2.6 million.
Panbela Therapeutics' pre-market drop indicates potential continued short-term bearishness as investors react to the negative price action.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 80
POSITIVE IMPACT
Alterity Therapeutics stock jumped by 196.98% to $4.93, with a market cap of $20.0 million.
Alterity Therapeutics' significant pre-market rise suggests a positive outlook that may continue as the market opens, potentially leading to short-term gains.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
EyePoint Pharmaceuticals stock soared by 378.8% to $31.65, with a market cap of $1.1 billion.
The substantial pre-market gain for EyePoint Pharmaceuticals indicates a strong positive sentiment that could lead to further short-term price increases as the market opens.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Lucy Scientific Discovery's stock increased by 95.33% to $0.41, with a market cap of $7.2 million.
The near doubling of Lucy Scientific Discovery's stock price in pre-market trading could lead to further short-term increases as the market responds to the positive momentum.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80